Leave Your Message

I-Telmisartan Ingcono i-antihypertensive Ukukhusela izintso

Ixabiso lokubhekisela: USD 0.2-0.8/g

  • Igama lemveliso I-Telmisartan
  • Inombolo yeCAS. 144701-48-4
  • MF I-C33H30N4O2
  • MW 514.629
  • EINECS 1592732-453-0

Inkcazo eneenkcukacha

I-Telmisartan, ekwabizwa ngokuba yi-Timosartan, lichiza elinokwehla loxinzelelo lwegazi elichazwe njenge-angiotensin II receptor (uhlobo lwe-AT1) oluchasayo. Isetyenziswa kakhulu kunyango loxinzelelo lwegazi oluyimfuneko, inika iingenelo ezininzi ngaphezu kwamanye amayeza e-antihypertensive. Esi sincoko sijolise ekunikeni isishwankathelo esibanzi seenzuzo zeTelmisartan kunye neengqwalasela ezibalulekileyo zokusetyenziswa kwayo.

Izinto eziluncedo kwiTelmisartan:

Isiphumo esingcono se-antihypertensive:
I-Telmisartan lichiza eliqhelekileyo elimiselweyo lodidi lokuqala lwe-antihypertensive ngenxa yokusebenza kwalo okuphezulu. Njengomchasi wohlobo lwe-AT1, inqanda isenzo se-angiotensin, okukhokelela ekunciphiseni okukhulu kwengcinezelo yegazi. I-Telmisartan ibonisa iqondo eliphezulu lokuchaneka xa kuthelekiswa nezinye i-sartan, eyivumela ukuba ingene ngokulula kwi-membrane yeeseli kwaye ijolise kwiiseli ezithile. Oku kukodwa kwandisa iziphumo zayo ze-antihypertensive, okukhokelela ekunciphiseni okukhulu koxinzelelo lwegazi. Ukongeza, iTelmisartan inesiqingatha sobomi obude, iqinisekisa ulawulo oluzinzileyo nolusebenzayo loxinzelelo lwegazi.

1716534799927t0h

Ukukhuselwa kwemithambo ye-cardiovascular and cerebral:

I-Telmisartan ibalasele njengeyodwa ichiza elifana ne-sartan elivunywe yi-FDA kwiipropathi zalo zokhuselo lwentliziyo kunye ne-cerebrovascular. Ibonisa ukukwazi ukubuyisela umva i-hypertrophy ye-ventricular yasekhohlo kwaye iyacetyiswa kwizigulane ezine-hypertension ehamba ne-left ventricular hypertrophy, insufficiency cardiac, okanye isifo se-coronary artery. Ukongeza kwiziphumo zayo zokunciphisa uxinzelelo lwegazi, iTelmisartan inciphisa ukonakala kwentliziyo kunye ne-cerebrovascular. Iluncedo kakhulu kubantu abaye bafumana i-stroke okanye i-cardiac infarction.

Ukukhusela umsebenzi wezintso:

Enye inzuzo yeTelmisartan yimpembelelo yayo entle ekusebenzeni kwezintso. Kuba iTelmisartan ifumana i-hepatic metabolism kwaye ikhutshelwa kwi-bile, inefuthe elincinci ekusebenzeni kwezintso. Ngaphezu koko, iTelmisartan ifunyenwe inciphisa iproteinuria, ngaloo ndlela ikhusela ukusebenza kwezintso. Iluncedo ngakumbi kwizigulana ezinoxinzelelo lwegazi kunye neemeko ze-comorbid ezifana ne-nephropathy yesifo sikashukela, i-microalbuminuria, i-proteinuria, okanye i-mild to moderate insuffence renal.

Ukuphucula ukunganyangeki kwe-insulin:

I-Telmisartan ibonise iziphumo ezilungileyo kwimetabolism ye-glucose kunye nokumelana ne-insulin. Olu phawu lwenza ukuba lube lukhetho olufanelekileyo kwizigulane ezine-hypertension kunye nesifo sikashukela, njengoko kunokunceda ukuphucula ukuvakalelwa kwe-insulin kunye nokulawula i-glucose.


171653478835774n17165347793698ts


I-Telmisartan, isichasi esithile se-angiotensin II receptor (uhlobo lwe-AT1), ibonelela ngeenzuzo ezininzi kunyango loxinzelelo lwegazi oluyimfuneko. Impembelelo yayo engcono ye-antihypertensive, ukukhuselwa kwemithambo ye-cardiovascular and cerebral, ukugcinwa komsebenzi wezintso, kunye nokuphuculwa kwe-insulin ukumelana kwenza kube yinto ebalulekileyo ekulawuleni uxinzelelo lwegazi kunye neemeko ezinxulumene nazo. Nangona kunjalo, kubalulekile ukulandela izikhokelo ezicetyiswayo malunga nexesha leyeza, ulawulo lwedosi, kunye nokujongwa rhoqo ukuze kuqinisekiswe ukusebenza kakuhle kunye nokhuseleko. Ukubonisana nengcali yezempilo kuhlala kucetyiswa ukuba ufumane iingcebiso zomntu kunye nesikhokelo malunga nokusetyenziswa kweTelmisartan okanye naliphi na iyeza.

Inkcazo

17165252945776jr